Results 71 to 80 of about 5,200 (157)

Infective endocarditis involving MitraClip© devices: a systematic literature review

, 2023
Purpose: Progress of interventional cardiology has boosted the use of newer cardiac devices. These devices are perceived to be less prone to infections compared to traditional surgical prostheses, but little data are currently available.
Bertolino L., Durante-Mangoni E., Zampino R., Ramadan M. S.   +3 more
core   +1 more source

Clinical outcomes of transcatheter edge‐to‐edge repair in patients with functional mitral regurgitation and pulmonary hypertension

European Journal of Clinical Investigation, Volume 56, Issue 1, January 2026.
This study reveals that patients with PH have worse clinical outcomes, in terms of hospitalization for heart failure (HF) and the composite endpoint of HF hospitalization and death at 1‐year follow‐up, compared with patients without PH. In particular, the hemodynamic subgroup of combined post‐ and pre‐capillary PH is associated with worse clinical ...
Alessandro Mandurino‐Mirizzi, Luca Raone, Andrea Raffaele Munafò, Fabrizio Gazzoli, Marco Mussardo, Claudio Montalto, Francesco Germinal, Marco Ferlini, Italo Porto, Giuseppe Colonna, Jacopo Oreglia, Gabriele Crimi   +11 more
wiley   +1 more source

Comparing Transcatheter Mitral Valve Replacement to Transcatheter Edge‐to‐Edge Repair in Mitral Regurgitation: A Systematic Review

Cardiovascular Therapeutics, Volume 2026, Issue 1, 2026.
Background Mitral regurgitation affects 2% of the population globally, with a widely increasing prevalence. Although mitral regurgitation is most commonly corrected by open surgery, there has been a recent shift toward less invasive transcatheter approaches, including both transcatheter edge‐to‐edge repair (TEER) and transcatheter mitral valve ...
Rama A. Safadi, Alaa Dean A. Esmail, Lauren E. DeProfio, Ahmed Adham R. Elsayed, Marc D. Basson, Irfan Ahmad   +5 more
wiley   +1 more source

Managing mitral regurgitation: focus on the MitraClip device

, 2016
J Trent Magruder,1 Todd C Crawford,1 Joshua C Grimm,1 Joseph L Fredi,2 Ashish S Shah3 1Division of Cardiac Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, 2Department of Medicine, Division of Cardiovascular Medicine, Vanderbilt ...
Magruder JT, Grimm JC, Shah AS, Fredi JL, Crawford TC   +4 more
core  

Transcatheter Tricuspid Valve Replacement in Patients After Prior Left‐Sided Valve Surgery: A Multicenter Retrospective Analysis

Journal of Interventional Cardiology, Volume 2026, Issue 1, 2026.
Background Functional tricuspid regurgitation (TR) after previous left‐sided valve surgery (LSVS) represents a significant proportion of all isolated TR cases; tricuspid valve reoperation in such patients, often in the advanced stage of disease, is historically regarded as high‐risk.
Tianyuan Xiong, Yi Zhang, Fan Qiao, Yuan Feng, Zhengang Zhao, Xin Wei, Xi Li, Fei Chen, Xingyu Ji, Junbo Ge, Fanglin Lu, Mao Chen, Irfan Ahmad   +12 more
wiley   +1 more source

MitraClip Implantation for Functional Mitral Regurgitation With Coaptation Gap Facilitated by Levosimendan Treatment

JACC: Case Reports, 2020
A patient with severe, symptomatic functional mitral regurgitation was initially considered not suitable for MitraClip (Abbott Vascular, Abbott Park, Illinois) implantation because of non-coapting mitral leaflets.
Athanasios Koutsoukis, MD, Damien Fard, MD, Romain Gallet, MD, PhD, Madjid Boukantar, MD, Emmanuel Teiger, MD, PhD, Annabelle Nguyen, MD, Raphaelle Huguet, MD, Pascal Lim, MD, PhD   +7 more
doaj   +1 more source

Effects of MitraClip Therapy on Mitral Flow Patterns and Vortex Formation: An In Vitro Study

, 2022
MitraClip transcatheter edge-to-edge repair is used to treat mitral regurgitation (MR). While MR is reduced, diastolic left ventricular flows are altered.
Boudoulas, Konstantinos Dean, Dasi, Lakshmi P., Gooden, Shelley Chee Mei, Vannan, Mani A., Hatoum, Hoda   +4 more
core   +1 more source

Impact of preinterventional tricuspid regurgitation on outcome of MitraClip therapy in patients with severely reduced ejection fraction

Open Heart, 2020
AimTo evaluate the impact of preinterventional moderate-to-severe functional tricuspid regurgitation (FTR) on early outcome after percutaneous edge-to-edge mitral valve repair (pMVR) with MitraClip procedures for functional mitral regurgitation (FMR) in ...
Takayuki Gyoten, Daniel Messroghli, Soeren Schenk, Kristin Rochor, Oliver Grimmig, Soeren Just, Dirk Fritzsche   +6 more
doaj   +1 more source

Prognostic Impact of Left Atrial Function Following Transcatheter Mitral Valve Repair

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019
Background Left atrial (LA) function predicts clinical outcome in a variety of cardiovascular diseases. However, limited data are available in the setting of mitral regurgitation.
Jakob Ledwoch, Katharina Leidgschwendner, Carmen Fellner, Felix Poch, Ida Olbrich, Ruth Thalmann, Hans Kossmann, Michael Dommasch, Ralf Dirschinger, Anja Stundl, Karl‐Ludwig Laugwitz, Christian Kupatt, Petra Hoppmann   +12 more
doaj   +1 more source

Clarifying the Scope of Native EHRA Type 2 Valvular Disease and Event Reporting in Anticoagulated Patients With Atrial Fibrillation

Clinical Cardiology, Volume 49, Issue 6, June 2026.
Jiaqi Chen, Mangmang Xu
wiley   +1 more source